East Asia Pharmaceutical: Ketoconazole API has obtained European CEP certification
2026-11-13 15:49:09
According to CoinMeta, East Asia Pharmaceutical announced that the company has received a Certificate of Compliance with the European Pharmacopoeia for the active ingredient ketoconazole (Certificate CEP) issued by the European Medicines Agency (EMA). At the same time, its wholly-owned subsidiary, Jiangxi Shanyuan Pharmaceutical Co., Ltd., has also received a Certificate of Compliance with the European Pharmacopoeia for the active ingredient flurbiprofen (Certificate EDQM).
Bullish 0
Bearish 0Share to 
Source：Jin10 Data
This content is for market information only and does not constitute investment advice.
Follow CoinMeta official accounts to stay updated
Hot Articles
Refresh
NVIDIA's stock tumbles 9% after the latest announcement; what impact will NVIDIA's decline have on the AI industry?
11-12 16:08
Is the Tangem wallet secure? No need to memorize a mnemonic phrase, can beginners use it with confidence?
11-12 17:31
SOL Currency's Latest Price Outlook: Can It Break Through the $90 Barrier?
11-11 11:59
Dow Jones 1,000-Point Swings: CPI Reversal or Bull Trap?
11-10 16:56
Coinbase Is the exchange safe? How can beginners in 2026 download and register?
11-09 19:09
